| To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors (NCT05253053) | TransThera Sciences (Nanjing), Inc. | 2022-04-13 |
| Artificial Intelligence-based Tumor Microenvironment Analysis for Prognosis Prediction in Gallbladder Cancer (NCT07092397) | Samsung Medical Center | 2022-04-05 |
| Association Between Cell-free Nucleic Acid in Blood, Urine and Microbiome in Stool With Pancreatobiliary Cancer (NCT05596370) | Seoul National University Hospital | 2022-01-06 |
| Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes (NCT04907643) | Cedars-Sinai Medical Center | 2021-10-05 |
| A Prospective Study of UCAD for Diagnosing Benign or Malignant Biliary Obstruction and Follow-up (NCT05237193) | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 2021-09-03 |
| Biomarker Discovery in Patients With Advanced Biliary Tract Cancer (NCT04871321) | CHA University | 2021-04-14 |
| Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors (NCT04742959) | TransThera Sciences (Nanjing), Inc. | 2021-03-14 |
| Poorly Differentiated Adenocarcinoma With Signet Ring Cells of the Gallbladder Producing a High Level of Alpha-fetoprotein: a Case Report (NCT05559229) | junya mita | 2021-01-15 |
| PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study) (NCT04484636) | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 2020-10-28 |
| The PLATON Network (NCT05489250) | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 2020-10-28 |
| Hepatobiliary Tumors Tissue Samples Acquisition (NCT04445532) | Peking Union Medical College Hospital | 2020-10-11 |
| Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors (NCT04383210) | Elevation Oncology | 2020-09-29 |
| Feasibility Study of Multi-Platform Profiling of Resected Biliary Tract Cancer (NCT04561453) | University of Washington | 2020-07-08 |
| Adjuvant Immunotherapy Combined With Chemoradiation for Patients With High-risk reseCtable Extrahepatic chOlangiocaRcinoma and gallblaDder Cancer (NCT04333927) | Sun Yat-sen University | 2020-06-01 |
| Neoadjuvant Gemcitabine Plus Cisplatin With or Without Durvalumab in Resectable Biliary Tract Cancer (NCT04308174) | Asan Medical Center | 2020-05-20 |
| Pembrolizumab in Biliary Tract Cancer (NCT03260712) | European Organisation for Research and Treatment of Cancer - EORTC | 2020-01-07 |
| EULAT Eradicate GBC (NCT06192719) | Centre Paul Strauss | 2019-12-01 |
| Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L BTC (NCT04066491) | EMD Serono Research & Development Institute, Inc. | 2019-09-20 |
| M7824 Monotherapy in Locally Advanced or Metastatic Second Line (2L) Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer) (NCT03833661) | EMD Serono Research & Development Institute, Inc. | 2019-03-26 |
| Comparing the Current Hydration Regimen for the ABC02 Chemotherapy Regimen Versus a Shorter Hydration (NCT04362449) | Imperial College Healthcare NHS Trust | 2019-01-02 |
| Three Dimension Laparoscopic Versus Open Surgery for Gallbladder Carcinoma (NCT03491878) | Tongji Hospital | 2018-05-01 |
| The Relationship Between Triceps Skinfold and Overall Survival of Pancreas, Bile Duct, Gallbladder Cancer (NCT03637569) | Samsung Medical Center | 2018-04-01 |
| NGS in Gallbladder Cancer and Response to Treatment (NCT05404347) | Banaras Hindu University | 2018-01-01 |
| Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC) (NCT03111732) | National Cancer Institute (NCI) | 2017-06-14 |
| Observational Study on Patients With Hepatobiliary Tumors (NCT04637048) | Gang Chen, MD | 2017-02-16 |
| Chile Biliary Longitudinal Study (NCT02692911) | National Cancer Institute (NCI) | 2017-01-11 |
| Molecularly Target Therapy With FORFIRINOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma (NCT03768375) | Shanghai Jiao Tong University School of Medicine | 2016-11-01 |
| Programs To Support You During Chemotherapy (NCT02489422) | Wake Forest University Health Sciences | 2016-08-01 |
| Molecularly Target Therapy With GEMOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma (NCT02836847) | Shanghai Jiao Tong University School of Medicine | 2016-07-01 |
| Chemothetapy FORFIRINOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma (NCT03772132) | Shanghai Jiao Tong University School of Medicine | 2016-07-01 |
| T Cell Mediated Adaptive Therapy for Her2-positive Neoplasms of Digestive System (NCT02662348) | Yi Miao | 2016-02-01 |
| A Study for Efficacy of Side-by-side Compared to Stent-in-stent Technique in the Endoscopic Management of Malignant Hilar Biliary Obstruction (NCT02659852) | Yonsei University | 2016-01-01 |
| International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) (NCT03210298) | Sabine Rhode | 2016-01-01 |
| Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer (NCT02293954) | City of Hope Medical Center | 2015-11-11 |
| Identification of New Biomarkers for Patients With Cholangiocarcinoma and Gallbladder Cancer (NCT05184400) | Herlev and Gentofte Hospital | 2015-01-01 |
| Alcohol Consumption and Gallbladder Cancer (NCT02326948) | Cheju Halla General Hospital | 2014-08-01 |
| The Effect in Wedge Resection and IVb/V Resection of the Liver for Gallbladder Cancer (NCT02920554) | Saint Vincent's Hospital, Korea | 2014-07-01 |
| Active Symptom Control Alone or With mFOLFOX Chemotherapy for Locally Advanced/ Metastatic Biliary Tract Cancers (NCT01926236) | The Christie NHS Foundation Trust | 2014-02-01 |
| Integrated Cancer Repository for Cancer Research (NCT02012699) | University of Nebraska | 2013-11-01 |
| Evaluation of the Effectiveness of Intraoperative Frozen Section on the Treatment of Suspected Gallbladder Cancer (NCT06189664) | Imperial College London | 2013-01-01 |
| Quebec Pancreas Cancer Study (NCT04104230) | George Zogopoulos | 2012-03-12 |
| Adjuvant Chemotherapy vs no Chemotherapy for Patients With GallBllader Carcinoma (NCT02778308) | Govind Ballabh Pant Institute of Postgraduate Medical Education and Research | 2012-01-01 |
| Gemcitabine, Oxaliplatin and Panitumumab in Kras/B-raf Wild-Type Biliary Track and Gallbladder Cancer (NCT01308840) | University of Rochester | 2010-12-01 |
| A Randomized, Open, Prospective Clinical Research of Fluorouracil Implant to Improve Surgical Gallbladder Cancer and Bile Duct Cancer (NCT01317069) | Simcere Pharmaceutical Co., Ltd | 2010-06-01 |
| Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer (NCT00987766) | Vanderbilt-Ingram Cancer Center | 2009-11-01 |
| Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer (NCT00903396) | Alliance for Clinical Trials in Oncology | 2009-09-01 |
| A Study of Combination of Gemcitabine, Oxaliplatin (GEMOX)-Sorafenib in Patients With Advanced Biliary Tract Cancer (NCT00955721) | University of Miami | 2009-08-01 |
| Gemcitabine and Cisplatin Plus Sorafenib in Patients With Advanced Biliary Tract Carcinomas Naive to Systemic Therapy (NCT00919061) | Memorial Sloan Kettering Cancer Center | 2009-08-01 |
| Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by Surgery (NCT01313377) | UNICANCER | 2009-07-01 |
| Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal Cancer (NCT00836992) | Mayo Clinic | 2009-01-01 |
| S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct (NCT00789958) | SWOG Cancer Research Network | 2008-12-01 |
| Radiation Stent Versus Self-expanding Metallic Stents (SEMS) for Palliative Treatment of Malignant Biliary Stricture (NCT01320241) | Southeast University, China | 2008-11-01 |
| Gemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary Cancer (NCT00658593) | NCIC Clinical Trials Group | 2008-10-10 |
| Vandetanib Gemcitabine Or Placebo Plus Gemcitabine Or Vandetanib Monotherapy In Advanced Biliary Tract Cancer (NCT00753675) | Genzyme, a Sanofi Company | 2008-10-01 |
| Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer (NCT00654160) | Mayo Clinic | 2008-06-01 |
| Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms (NCT01640522) | University of Pittsburgh | 2008-01-01 |
| Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial Therapy (NCT00896467) | Centre Oscar Lambret | 2007-09-01 |
| Gemcitabine, Oxaliplatin, Tarceva &/or Cisplatin in HCC & Biliary Tree Cancers (NCT00832637) | New Mexico Cancer Research Alliance | 2007-08-01 |
| Biliary Stenting With or Without Photodynamic Therapy in Treating Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors That Cannot Be Removed by Surgery (NCT00513539) | University College, London | 2007-07-01 |
| Storage of Bile From Routine Procedures to Study Risk Factors (NCT00414843) | Indiana University | 2006-12-01 |
| Study to Test the Benefit and Safety of GM-CT-01 in Combination With 5-FU to Treat Bile Duct and Gall Bladder Cancer (NCT00386516) | Galectin Therapeutics Inc. | 2006-09-01 |
| Avastin and Tarceva for Upper Gastrointestinal Cancers (NCT00350753) | Rigshospitalet, Denmark | 2006-06-01 |
| Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer (NCT00363584) | University Hospital Southampton NHS Foundation Trust | 2006-03-01 |
| Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer (NCT00387348) | Massachusetts General Hospital | 2006-03-01 |
| Biliary Metal Stent Study: Metal Stents for Management of Distal Malignant Biliary Obstruction (NCT00280709) | University Hospital, Linkoeping | 2006-01-01 |
| Palliative Biliary Stenting on the Quality of Life of Patients With Unresectable Carcinoma Gallbladder With Hiliar Block. (NCT00391183) | All India Institute of Medical Sciences | 2006-01-01 |
| Fluorouracil, Cisplatin, and Radiation Therapy or Gemcitabine and Oxaliplatin in Treating Patients With Nonmetastatic Biliary Tract Cancer That Cannot Be Removed By Surgery (NCT00304135) | Federation Francophone de Cancerologie Digestive | 2005-10-01 |
| Quality Of Life in Patients With Malignant Biliary Obstruction (NCT00579865) | Memorial Sloan Kettering Cancer Center | 2005-05-01 |
| Gemcitabine With or Without Cisplatin in Treating Patients With Unresectable Locally Advanced or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors (NCT00262769) | University College, London | 2005-05-01 |
| Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer (NCT00486356) | University of Nebraska | 2004-10-01 |
| Gemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer (NCT00059865) | Alliance for Clinical Trials in Oncology | 2004-01-01 |
| Endoscopic Versus Percutaneous Drainage For Hilar Block in Gall Bladder Cancer (NCT00409864) | All India Institute of Medical Sciences | 2003-10-01 |
| S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangiocarcinoma (NCT00033540) | SWOG Cancer Research Network | 2003-09-01 |
| Adjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract Cancer (NCT00073905) | Swiss Cancer Institute | 2003-04-01 |
| Gemcitabine and Capecitabine in Treating Patients With Advanced and/or Inoperable Cholangiocarcinoma or Carcinoma of the Gallbladder (NCT00084942) | Roswell Park Cancer Institute | 2002-10-01 |
| A Feasibility Phase II Study in the Treatment of Resected Cholangiocarcinoma, Gallbladder, Pancreatic and Ampullary Cancers (NCT00660699) | Washington University School of Medicine | 2002-09-01 |
| Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract (NCT00012246) | The University of Texas Medical Branch, Galveston | 2002-07-01 |
| Gemcitabine and Cisplatin for Gallbladder and Biliary Tract Cancer (NCT00123825) | Dana-Farber Cancer Institute | 2002-07-01 |
| HAI Via Interventionally Implanted Port Catheter Systems (NCT00356161) | Charite University, Berlin, Germany | 2002-04-01 |
| Study of Gemcitabine and Carboplatin in the Treatment of Metastatic or Recurrent Cholangiocarcinoma/Gallbladder Cancer (NCT00660140) | Washington University School of Medicine | 2002-03-01 |
| Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer (NCT00027534) | Michael Morse, MD | 2002-01-01 |
| Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer (NCT00009893) | Alliance for Clinical Trials in Oncology | 2001-05-01 |
| Anonymous Testing of Pathology Specimens for BRCA Mutations in Ashkenazi Jewish Individuals Who Have Cancer (NCT00588263) | Memorial Sloan Kettering Cancer Center | 2000-07-01 |
| DX-8951f in Treating Patients With Biliary Cancer (NCT00005938) | Daiichi Sankyo | 2000-03-01 |
| Rebeccamycin Analogue in Treating Patients With Advanced Liver and/or Biliary Cancer (NCT00005997) | Case Comprehensive Cancer Center | 1999-04-01 |
| Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or Pancreas (NCT00003923) | Memorial Sloan Kettering Cancer Center | 1999-03-01 |
| Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder (NCT00489515) | Wake Forest University Health Sciences | 1999-02-01 |
| Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder Cancer (NCT00003557) | University of Chicago | 1999-01-01 |
| Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic Cancer (NCT00003411) | University of Pittsburgh | 1998-11-01 |
| Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas (NCT00019513) | National Institutes of Health Clinical Center (CC) | 1998-08-01 |
| Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer (NCT00003276) | Alliance for Clinical Trials in Oncology | 1998-03-01 |
| Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer (NCT00003296) | Brown University | 1998-01-01 |
| Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer (NCT00544193) | City of Hope Medical Center | 1997-12-01 |
| Interleukin-12 in Treating Patients With Cancer in the Abdomen (NCT00003046) | M.D. Anderson Cancer Center | 1997-08-01 |
| Biological Therapy in Treating Patients With Metastatic Cancer (NCT00004604) | Duke University | 1997-02-01 |